Single gene behind essential tremor, Parkinson’s disease identified

Washington, September 2 (ANI): A single gene promotes development of essential tremor in some patients and Parkinson’s disease in others has been identified by an international team of researchers.

In a study report published in Parkinsonism and Related Disorders, Mayo Clinic researchers in Florida and their collaborators worldwide note that patients with essential tremor shake when they move, while those with Parkinson’s disease shake when they are at rest.

They further state that a variant in LINGO1, a gene involved in neuronal survival, is the first proven evidence of a common genetic component in the development of both disorders.

Analysing their findings, the researchers have come to the conclusion that mutations in this gene are potentially responsible for five percent of patients with Parkinson’s disease, and five percent of patients with essential tremor.

Lead researcher Dr. Carles Vilarino-Guell, of Mayo Clinic, said: “There is a mutation in the gene that must be causing or contributing to Parkinson’s disease in some people and essential tremor in others.”

He, however, added that that did not mean that people with essential tremor have an increased risk of developing Parkinson’s disease.

The findings are intriguing because “although essential tremor and Parkinson’s disease are considered to be different diseases, researchers have been arguing for a long time about whether essential tremor is a milder, preliminary form of Parkinson’s disease, and they have been looking for the genetic connection between these disorders,” he said.

“Now we know LINGO1 is the first gene identified,” he added.

The scientists have yet to identify any specific mutation or mutations on LINGO1 responsible for either disorder.

“The easiest explanation is that there are two separate and clearly distinct mutations in the gene contributing to the disorders. But because this gene doubles the risk of developing either disease and it is found at the same frequency in both diseases, it is possibly the same mutation,” Dr. Vilarino-Guell said.

“Both diseases are also affected by environmental factors, and that may influence which disorder a person would be more likely to develop,” he added. (ANI)

US navy chemists try to turn seawater into jet fuel

London, August 19 (ANI): In a new experiment, US navy chemists have processed seawater into unsaturated short-chain hydrocarbons that with further refining could be made into kerosene-based jet fuel.

According to a report by New Scientist, the process involves extracting carbon dioxide (CO2) dissolved in the water and combining it with hydrogen – obtained by splitting water molecules using electricity – to make a hydrocarbon fuel.

It uses a variant of a chemical reaction called the Fischer-Tropsch process, which is used commercially to produce a gasoline-like hydrocarbon fuel from syngas, a mixture of carbon monoxide and hydrogen often derived from coal.

Robert Dorner, a Naval Research Laboratory chemist in Washington DC and first author of a new paper on the technique, said that CO2 is rarely used in the Fischer-Tropsch process because of its chemical stability.

“But CO2′s abundance, combined with concerns about global warming, make it an attractive potential feedstock,” Dorner said.

“Although the gas forms only a small proportion of air – around 0.04 per cent – ocean water contains about 140 times that concentration,” he added.

The navy team has been experimenting to find out how to steer the CO2-producing process away from producing unwanted methane to produce more of the hydrocarbons wanted.

In the conventional Fischer-Tropsch process, carbon monoxide and hydrogen are heated in the presence of a catalyst to initiate a complex chain of reactions that produce a mixture of methane, waxes and liquid fuel compounds.

Dorner and colleagues found that using the usual cobalt-based catalyst on seawater-derived CO2 produced almost entirely methane gas.

Switching to an iron catalyst resulted in only 30 per cent methane being produced, with the remainder short-chain hydrocarbons that could be refined into jet fuel.

According to Heather Willauer, the navy chemist leading the project, the efficiency needs to be much improved, perhaps by finding a different catalyst. (ANI)

Why sleep deprivation affects some people more than others

Washington, June 25 (ANI): Conducting a new imaging research, scientists have explained why sleep deprivation affects some people more than others.

Researchers observed that people who are genetically vulnerable to sleep loss showed reduced brain activity after staying awake all night, while those who are genetically resilient showed expanded brain activity.

The findings help explain individual differences in the ability to compensate for lack of sleep.

“The extent to which individuals are affected by sleep deprivation varies, with some crashing out and others holding up well after a night without sleep,” said Dr. Michael Chee, at the Duke-National University of Singapore Graduate Medical School.

In the current study, the researchers, led by Dr. Pierre Maquet, at the University of Liege in Belgium selected study participants based on their genes.

Previous research showed that the PERIOD3 (PER3) gene predicts how people will respond to sleep deprivation. People carry either long or short variants of the gene.

Those with the short PER3 variant are resilient to sleep loss – they perform well on cognitive tasks after sleep deprivation.

However, those with the long PER3 variant are vulnerable – they show deficits in cognitive performance after sleep deprivation. Now the new study explains why.

The authors imaged study participants while they did a working memory task that requires attention and cognitive control – also called executive function.

They found that the resilient, short gene variant group compensated for sleep loss by “recruiting” extra brain structures.

Besides brain structures normally activated by the cognitive task, these participants showed increased activity in other frontal, temporal, and subcortical brain structures after a sleepless night.

On the other hand, after a sleepless night, vulnerable participants, the long PER3 group, showed reduced activity in brain structures normally activated by the task.

These participants also showed reduced brain activity in one brain structure – the right posterior inferior frontal gyrus – after a normal waking day.

The above data is consistent with previous research suggesting that people with the long gene variant perform better on executive tasks earlier, but not later, in the day.

“Our study uncovers some of the networks underlying individual differences in sleep loss vulnerability and shows for the first time how genetic differences in brain activity associate with cognitive performance and fatigue. The data also provide a basis for the development of measures to counteract individual cognitive deficits associated with sleep loss,” said study author Maquet.

The study is published in the latest issue of The Journal of Neuroscience. (ANI)

‘DNA Sudoku’ to revolutionise genome sequencing, medical genetics

Washington, June 25 (ANI): Sudoku, the popular mathematics puzzle that has taken people by storm, is now set to revolutionize the world of genome sequencing and the field of medical genetics, according to a new study.

Researchers at Cold Spring Harbor Laboratory (CSHL) have combined 2,000-year-old Chinese math theorem with concepts from cryptologyto develop what they dubbed as the “DNA Sudoku”, because of its similarity to the logic and combinatorial number-placement rules used in the popular game.

The strategy allows tens of thousands of DNA samples to be combined, and their sequences – the order in which the letters of the DNA alphabet (A, T, G, and C) line up in the genome – to be determined all at once.

The accomplishment is quiet contrary to past approaches that allowed only a single DNA sample to be sequenced at a time.

It also has an upper hand on current approaches that, at best, can combine hundreds of samples for sequencing.

“In theory, it is possible to use the Sudoku method to sequence more than a hundred thousand DNA samples,” said CSHL Professor Gregory Hannon, leader of the team that invented the “Sudoku” approach.

With such efficiency, the approach promises to reduce costs dramatically.

The new method has tremendous potential for clinical applications. It can be used, for example to analyse specific regions of the genomes of a large population and identify individuals who carry mutations that cause genetic diseases – a process known as genotyping.

The key to the team’s innovation is the pooling strategy, which is based on the 2,000-year-old Chinese remainder theorem.

The method is currently best suited for genotype analyses that require only short segments of an individual’s genome to be sequenced to find out if the individual is carrying a certain variant of a gene or a rare mutation.

However, with the improvement in sequencing technologies and researchers gaining the ability to generate sequences for longer segments of the genome, Hannon envisions wider clinical applications for their method such as HLA typing, already an important diagnostic tool for autoimmune diseases, cancer, and for predicting the risk of organ transplantation.

The report will be published as the cover story in the July 1 issue of the journal Genome Research.(ANI)

Genetic link between dental disease, heart attack identified

Washington, May 25 (ANI): Scientists from University of Kiel, Germany have identified a genetic link between dental disease periodontitis and coronary heart disease (CHD).

Dr. Arne Schaefer, of the Institute for Clinical Molecular Biology, University of Kiel, Germany, said that they have discovered a genetic variant situated on chromosome 9, which was shared between the two diseases.

“We studied a genetic locus on chromosome 9p21.3 that had previously been identified to be associated with myocardial infarction, in a group of 151 patients suffering from the most aggressive, early-onset forms of periodontitis, and a group of 1097 CHD patients who had already had a heart attack,” he said.

“The genetic variation associated with the clinical pictures of both diseases was identical,” he added.

The further analysis of 1100 CHD patients and 180 periodontitis patients showed that the genetic risk variant is located in a genetic region that codes for an antisense DNA called ANRIL and that it is identical for both diseases.

Both CHD and periodontitis are propagated by the same risk factors – most importantly smoking, diabetes and obesity – and there is also a gender relationship, with men possibly more liable to these diseases than women.

“These factors already indicated a possible mutual genetic basis underlying the two diseases”, said Schaefer.

“Now we know for sure that there is a strong genetic link, patients with periodontitis should try to reduce their risk factors and take preventive measures at an early stage.

“We hope that our findings will make it easier to diagnose the disease at an early stage, and that in future a greater insight into the specific pathophsyiology might open the way to effective treatment before the disease can take hold,” he added.

The study was presented at the annual conference of the European Society of Human Genetics. (ANI)

Gene linked to autism risk identified

Washington, May 20 (ANI): A new study from University of California, Los Angeles has identified a genetic variant that may increase a child’s risk of developing autism, particularly boys.

The research team has discovered a variant of a gene called CACNA1G that, according to the researchers, that makes boys four times more likely to develop autism, than girls.

“This is a strong finding,” said Dr. Stanley Nelson, professor of human genetics at the David Geffen School of Medicine at UCLA.

“No one has scrutinized the role that CACNA1G plays in autism.

“We found that a common form of the gene occurs more frequently in the DNA of families that have two or more sons affected by autism, but no affected daughters.

“Our study may explain why boys are more susceptible to the disorder than girls,” he added.

Researchers zeroed in on a region of Chromosome 17 that previous studies have tied to autism.

They scoured the DNA of 1,046 members of families with at least two sons affected by autism for common gene variants and identified genetic markers to CACNA1G, which helps move calcium between the cells.

They discovered that the gene has a common variant that appears in the DNA of nearly 40 percent of the population.

“This alternate form of CACNA1G consistently increased the correlation to autism spectrum disorder, suggesting that inheriting the gene may heighten a child’s risk of developing autism,” said Nelson.

“This variant is a single piece of the puzzle. We need a larger sample size to identify all of the genes involved in autism and to solve the whole puzzle of this disease,” he added.

The study appears in journal Molecular Psychiatry. (ANI)

Why some pregnant women find it difficult to quit smoking

Washington, May 15 (ANI): Scientists from Peninsula Medical School and the University of Bristol have discovered a common genetic variant that might make it difficult for women to quit smoking during pregnancy.

They found that variation in 15q24 nicotinic acetylcholine receptor gene receptor cluster is associated with a reduced ability of women to quit smoking in pregnancy.

For the study, the researchers looked at 7,845 women of European descent from the South West of England.

Using 2,474 women who smoked regularly immediately before they became pregnant, the association between the variant and smoking cessation and smoking quantity during pregnancy was analysed.

When asked about smoking in the first trimester of pregnancy, 28 pct of the women said they had given up.

However, this figure was only 21pct in the group of women with two copies of the smoking addiction gene, whereas in women with two copies of the non-addictive gene, 31pct said they had quit.

In the third trimester, 47pct of women with two copies of the non-addictive gene had stopped smoking, compared with only 34pct of women with two copies of the smoking addiction gene.

“Pregnant women are under considerable health and social pressure to stop smoking, and quitting in such circumstances is influenced by a number of factors including the age of the expectant mother, their education and whether or not their partners smoke,” said Dr. Rachel Freathy from the Peninsula Medical School.

“However, we were keen to investigate whether the genetic variant that influences increased cigarette consumption also had a role to play as an extra hurdle to quitting smoking during pregnancy, and our study suggests that it does,” she added.

The study is published in Human Molecular Genetics. (ANI)

Novel genetic risk factors for kidney disease identified

London, May 11 (ANI): Scientists have found three genes with common mutations that are associated with altered kidney disease risk.

One of the discovered genes, the UMOD gene, produces Tamm-Horsfall protein, the most common protein in the urine of healthy individuals, which was recently found to be linked with chronic kidney disease risk.

Chronic kidney disease is characterized by reduced kidney function or kidney damage. Its progression may lead to kidney failure, and the need for dialysis or transplantation.

It also increases the risk of cardiovascular diseases, mortality and medication side effects.

For the study, the researchers conducted genome-wide association studies of more than 20,000 people enrolled in four large population-based studies of cardiovascular disease risk factors, and even replicated their findings in another 20,000 participants.

Out of more than 2,500,000 genetic variants that were evaluated for each study participant, only three genes, UMOD, SHROOM3, and STC1 were found to be novel risk genes for reduced kidney function and chronic kidney disease.

“Previous research showed that rare mutations in the UMOD gene cause hereditary forms of severe kidney disease. Our research indicates that a common genetic variant with a frequency of 18 percent in populations of European ancestry is associated with about 25 percent lower risk of chronic kidney disease,” Nature magazine quoted Dr. Anna Kottgen, a researcher at Johns Hopkins and lead author of the study, as saying.

“We have known for a long time that a higher level of proteins, such as albumin, which aren’t usually present in urine, is a risk factor for kidney disease and its progression. The UMOD finding suggests that Tamm-Horsfall protein, which is thought to be a normal part of the urine, deserves attention since its genetic variation relates to risk,” said Dr. Josef Coresh, professor at Johns Hopkins.

He added: “For all three genes the findings are novel and suggest brand new areas for investigation including the need for developing methods to measure levels in urine or blood.”

The findings have been published in the journal Nature Genetics. (ANI)

Genetic make-up may influence one’s economic decisions

Washington, May 6 (ANI): It’s the genetic make-up of a person that determines how he or she would take economic decisions on the basis of whether the options have been framed negatively or positively, according to a study from University College London (UCL).

Decision-making is a complex process, particularly when we are uncertain about outcomes, which in turn depends on whether the options are phrased positively or negatively, known as the “framing effect”.

In earlier research, it was found that the amygdala, an area of the brain known to be involved in processing emotions, becomes active during decisions influenced by the framing effect.

And, in the new study, the researchers have shown that a person’s susceptibility to the framing effect – and the response of their amygdala – could be at least partially influenced by their genetic make-up.

“We know that people from across a variety of cultures are susceptible to biases when making decisions, and that even with training these biases are hard to overcome. This implies that hard-wired genetic influences might play an important role in determining how susceptible different individuals are to the framing effect,” said Dr Jonathan Roiser from the UCL Institute of Cognitive Neuroscience.

They showed that decision-making is affected by variation in the serotonin transporter gene, at a region known as the 5-HTTLPR, which has previously been reported to affect the response of the amygdala and is

The gene is involved in the recycling of serotonin, a neurotransmitter essential for communication between nerve cells.

The researchers analysed two common variants of this gene, known as the “short” and “long” versions and selected thirty healthy volunteers carrying a pair of either of the two variants.

Essentially, those participants with two copies of the short variant were found to be more susceptible to the framing effect.

“This doesn’t mean that people with the short variants are risk takers. In fact, they were risk averse in the ‘gain frame’ whilst risk seeking in the ‘loss frame’, which implies inconsistency in their decision-making,” explained Roiser.

On taking brain images, it was found that participants with two copies of the short genetic variant had greater amygdala responses than their counterparts when making decisions influenced by the frame effect.

They also measured the degree of interaction, or connectivity, between the amygdala and the prefrontal cortex, the brain region most implicated in human intelligence, personality and decision-making

And it was found that while resisting the frame effect, the participants with two copies of the long variant had stronger connectivity between the prefrontal cortex and amygdala, while those with a pair of short variants did not.

“This difference in connectivity is really interesting. It suggests that the volunteers carrying the long variant might regulate automatic emotional responses, which are driven by the amygdala, more efficiently, lessening their vulnerability to the framing effect,” said Roiser.

The study has been published in the Journal of Neuroscience. (ANI)

Bill and Melinda Gates pour thousands into unconventional health research

London, May 5 (ANI): Bill and Melinda Gates Foundation has thrown a lifeline to number of projects like creating an anti-viral tomato, a flu-resistant chicken and a magnet that can detect malaria, awarding 81 grants of one lakh dollar each in a bid to support innovative, unconventional global health research.

The five-year health research grants are designed to encourage scientists to pursue bold ideas that could lead to breakthroughs, focusing on ways to prevent and treat infectious diseases, such as HIV, malaria, tuberculosis, pneumonia and diarrhoeal diseases.
Among the grant recipients is Eric Lam at Rutgers University in New Jersey, who is exploring tomatoes as an antiviral drug delivery system, The Telegraph reported.

Three British scientific teams, pursuing novel approaches to preventing and treating infectious diseases such as tuberculosis, malaria and pneumonia, have been chosen.

One team, led by researchers at the University of Exeter in Devon, England, will seek to build an inexpensive instrument to diagnose malaria by using magnets to detect the waste products of the malaria parasite in human blood.

Scientists from Royal Holloway University, London, are attempting to compile a library of all possible mutations of HIV with the ultimate goal of a vaccine that can protect against many variant forms of the virus.

Each grant recipient will also get the chance of follow-on grants of one million dollar if their projects show success.

Applicants were selected from more than 3,000 proposals, with all levels of scientists represented – from veteran researchers to postgraduates – and a range of disciplines, such as neurobiology, immunology and polymer science. (ANI)

Swiss flu medicine company sees stock rise on back of outbreak

Geneva – The Swiss pharmaceutical giant Roch, maker of influenza medication Tamiflu, saw its stock price rise 3.8 per cent in early trading Monday on the Zurich exchange on the back of the global swine flu outbreak. During the avian flu epidemic the drug was used heavily, particularly in South Asia.

Shares in Roche were trading at close to 145 Swiss francs (126 dollars), up over five francs since the opening.

Martina Rupp, a spokeswoman for Roche, said Tamiflu was deemed to be effective against the swine variant.

“Tamiflu can always be used,” she explained, noting that as an antiviral, unlike vaccines, it did not need to be adjusted to specific strains of flu.

The research department at Roche was however looking into dosing schemes, checking to see “how much and for how long,” meaning how many pills should be taken and over what period, to achieve maximum effectiveness.

Rupp said Roche had donated in recent years 5 million doses of Tamiflu to the World Health Organisation.

Of these, 2 million were distributed “to stockpiles in countries not yet well prepared” in the developing world. From the remaining doses, the company had 1.5 million doses in Switzerland and an identical amount in the US on standby as a “fire-blanket,” to be distributed if needed in case of a pandemic.

“We are waiting for WHO to ask us to deploy,” Rupp said, noting that the company had the capacity to ramp up production if that was requested by the international organization. She added that in 2005, the full production capacity was never used.

The WHO was preparing for the second meeting of its International Health Regulation Committee on Tuesday, after having convened one session over the weekend.

A World Health Organization official said on Sunday that the world was better prepared for the current situation of swine flu, owing to steps taken by governments during the avian outbreak, including the stockpiling of needed drugs. (dpa)

Native Americans descended from a single ancestral group

Washington, April 30 (ANI): In a new research, an international team of scientists has determined that the Native Americans, who came to the New World, descended from a single ancestral group.

“Our work provides strong evidence that, in general, Native Americans are more closely related to each other than to any other existing Asian populations, except those that live at the very edge of the Bering Strait,” said Kari Britt Schroeder, a lecturer at the University of California, Davis, and the first author on the paper describing the study.

“While earlier studies have already supported this conclusion, what’s different about our work is that it provides the first solid data that simply cannot be reconciled with multiple ancestral populations,” he added.

The research team, which was headed by Noah Rosenberg at the University of Michigan, scrutinized DNA samples of people from 31 modern-day Asian populations, 19 Native American, one Greenlandic and two western Beringian populations.

The team’s work follows up on earlier studies by several of its members who found a unique variant (an allele), dubbed the “9-repeat allele,” of a genetic marker in the DNA of modern-day Native American people.

They found that in each sample that contained the 9-repeat allele, short stretches of DNA on either side of it were characterized by a distinct pattern of base pairs, a pattern they seldom observed in people without the allele.

“If natural selection had promoted the spread of a neighboring advantageous allele, we would expect to see longer stretches of DNA than this with a similarly distinct pattern,” Schroeder said.

“And we would also have expected to see the pattern in a high frequency even among people who do not carry the 9-repeat allele. So we can now consider the positive selection possibility unlikely,” he added.

The results also ruled out the multiple mutations hypothesis.

If that had been the case, there would have been myriad DNA patterns surrounding the allele rather than the identical characteristic signature the team discovered.

“There are a number of really strong papers based on mitochondrial DNA – which is passed from mother to daughter – and Y-chromosome DNA – which is passed from father to son – that have also supported a single ancestral population,” Schroeder said.

“But, this is the first definitive evidence we have that comes from DNA that is carried by both sexes,” he added. (ANI)

Progressive hearing loss in humans and mice linked to microRNA mutation

Washington, Apr 13 (ANI): By conducting parallel studies in human and mouse, two groups of scientists have found that a new kind of gene, called a microRNA, is linked with progressive hearing loss.

MicroRNA is a tiny fragment of RNA that affects the production of hundreds of other molecules within sensory hair cells of the inner ear.

One team, led by researchers from the Hospital Ramon y Cajal, Madrid, Spain, followed families who showed hearing loss.

The second team, led by researchers from the Wellcome Trust Sanger Institute, Cambridge, UK, examined a new line of mice, called diminuendo, that showed progressive hearing loss from an early age.

And in the end, the two groups shared their emerging data.

“We were able quite quickly to show that if the mice carried one copy of the gene variant they suffered progressive hearing loss, if they carried two variants they were profoundly deaf. The important questions were could we determine what the variant is and how does it exert its effect on hearing?” explained Professor Karen Steel, principal investigator of the programme at the Wellcome Trust Sanger Institute.

In their studies of families with progressive hearing loss, the Spanish team had suggested that the gene responsible lay on human chromosome 7.

For the study, both teams sequenced every gene in the equivalent genomic regions in human and mouse identified as implicated in hearing loss.

The sequencing showed that most of the genes in the region could not have any role to play in hearing loss.

However, each of the team found that a mutation in a microRNA gene called miR-96 was associated with the hearing loss.

“We know of a number of genes involved in deafness in humans and mice but, to our great surprise, this was one of a new class of genes called microRNAs,” explained Professor Miguel Angel Moreno-Pelayo, senior author on the human study.

Understanding the mechanism by which miR-96 leads to progressive hearing loss could provide clues to help develop therapies to improve the effects of progressive deafness, regardless of the trigger. (ANI)

Extensions add new functions to OpenOffice

Kaufbeuren, Germany – The basic version of the free office software suite, OpenOffice, packs in a lot of functionality. Yet for some users it’s just not enough. Fortunately it doesn’t need to be. A variety of extensions, most available for free, can be used to add even more pep to the standard version. This type of modular software construction is familiar to users of web browsers like Firefox and Opera as an effective way to integrate expanded capabilities. As with OpenOffice itself, these are free software add-ons developed by enthusiastic developers from the OpenOffice community.

“The spectrum of extensions ranges from tweaks to small details up to extensive expansions of the core functionality,” says Florian Effenberger, spokesman for the OpenOffice. org project.

The central English-language repository is available at http://extensions.services.openoffice.org and includes roughly 300 extensions. Yet, not all extensions are indexed there. Effenberger presumes that hundreds more of the little utilities are out there as well.

One popular type of extension is document templates. Another is PDF Import Extension, which enables users to edit PDF files. While the basic version of OpenOffice can open files of that kind, it can’t work edits back into the original very effectively. Also, adjusting the size of columns and rows in the Calc spreadsheet software can be tiring. CalcEasyToolbar makes it easier.

Presenter Console is a potentially useful aid for users who frequently create presentations in the OpenOffice module Impress. It provides a preview of the new slide, but only on the speaker’s monitor. Presentations with heavy multimedia content can be put on a diet using Presentation Minimizer. The extension makes presentations easier to open and e-mail.

If the user encounters an unknown term, Wikipedia can frequently provide quick assistance. The OOoWikipedia allows users to query the free encyclopedia from within the software directly. Anyone looking to create a Wikipedia article themselves can benefit from Wiki Publisher: a Wizard helps prepare articles composed in OpenOffice’s word processor Writer for publication on the Web. Along similar lines, the Weblog Publisher makes it easy to compose blog entries.

The extensions are easy to install. One option is to double click the already downloaded extensions with the file ending .”oxt.” The on-screen instructions will make it easy from there. The alternative is to use the Extension Manager’ in OpenOffice under the Extras menu. Extensions can be added, deactivated, or removed there.

Yet not every extension runs with every variant of OpenOffice. The safest bet, according to spokesman Florian Effenberger, is to use the current version, OpenOffice version 3. (Internet: http://extensions.services.openoffice.org, http://oooconv.free.fr/wikipedia/wikipedia_en.html, http://de.openoffice.org/downloads/komponenten.html, www.ooomacros.org, www.office-center-epj.de). (dpa)

Handling “bossnappings” poses dilemma for Sarkozy

A spate of “bossnappings” by French workers has put President Nicolas Sarkozy in a tight spot, caught between the need to enforce the law and the risk of exacerbating unrest during the economic downturn.

Managers have been held hostage at factories for up to 24 hours by staff angry about layoff plans in four separate incidents since March 12. In a variant, a billionaire boss was blocked in his taxi by employees for an hour on March 31.

“What’s this about holding people captive? We have the rule of law in this country. I will not let such things happen,” Sarkozy told a group of entrepreneurs on Tuesday.

The same day, workers at a British-owned plant detained four managers, including three Britons, and held them overnight. As in the three previous bossnappings, police did not intervene. Staff let the managers go on Wednesday after promises of talks.

Apart from the humiliation of seeing his warning ignored, Sarkozy now faces a dilemma in how to handle similar incidents.

Employers’ groups and politicians from his own centre-right camp say such acts are unacceptable.

“However difficult the situations faced by employees, it is not acceptable to break the law,” three bosses’ groups said in a joint statement this week.

But labour unions and the left-wing opposition say workers facing layoffs in a context of recession and booming unemployment are desperate, so these acts are understandable.

“I’m against violence but if these things keep happening it’s because there is an underlying despair,” said Socialist legislator Jean-Marc Ayrault on Canal+ television on Thursday.

PUBLIC OPINION SPLIT

Public opinion is split. A poll released on Tuesday found that 50 percent of people surveyed objected to bossnappings while 45 percent said they were acceptable.

Sarkozy’s own ratings have tumbled during the downturn and he is particularly unpopular among blue-collar workers.

His Tuesday comments against bossnappings angered workers at a plant run by U.S. company Caterpillar who detained their managers on March 31. Sarkozy had promised to “save” them and invited them to meet him, but they rejected the invitation.

“I don’t see why we should go and see him just so he can politely insult us, since he seems to think we are delinquents for having detained management for a few hours,” said Alain Debain, one of the Caterpillar workers, on i-Tele on Thursday.

The risk of sending in the riot police when the next hostage-taking occurs is that, far from discouraging such acts, it could cause them to proliferate.

Turning a blind eye carries risks as well. All four plants where bossnappings have occurred are foreign-owned, and the head of the CGPME employers’ group, which represents small and medium businesses, said foreign investors could be put off France.

“Maybe companies that have their headquarters abroad will decide to stop investing in our country and that would not be to the advantage of France or of our workers,” CGPME head Jean-Francois Roubaud told i-Tele.

Around 22,000 foreign companies employ more than 2 million people in France, according to the Invest in France agency.

Skoda to ramp up Aurangabad plant capacity; to launch four new models in India!

The encouraging bookings and sales of its cars in India has given Czech auto giant Skoda the confidence to work out new plans for the country.

The company, part of German automaker Volkswagen, intends ramping up its Aurangabad plant capacity where the cars are assembled with five per cent locally-sourced components; as well as launching four new models by next year!

At the India launch of the Skoda Superb 2.0 TDI PD diesel variant – the V6 petrol version being already launched in Delhi – Director-Sales and Marketing, Thomas Kuehl informed reporters about the company’s plans of venturing into the small car, MPV and SUV segments in India.

Upbeat about the response the Skoda cars are getting in India, Kuehl said: “We sold 515 cars of all models last year. In the last 30 days, we have sold 300 units and booked orders for 300 more cars. The Aurangabad facility is flexible enough to assemble up to 40,000 units, so coping with more numbers will be easy. We are firmly positioned in the ‘D’ segment as No: 2 and had a 38 per cent growth last year.”

Skoda, which is also aiming at increasing the local content in its cars by next year, might gradually phase out its mid-market segment entrant Octavia; and bring in an estate-variant of the Skoda Fabia, its MPV Roomster, and its SUV Yeti!

Potential new drug target to stop Alzheimer’s progression identified

Washington, Mar 20 (ANI): Scientists have moved a step closer to developing a drug that could actually stop the progress of Alzheimer’s disease.

They have identified a molecule that can form the basis for a new therapy for the neurodegenerative disease.

A typical characteristic of the brains of Alzheimer’s patients is the presence of amyloid plaques, which are abnormal accumulations of the _-amyloid protein between the neurons. The sticky _-amyloid arises when the amyloid precursor protein is cut into pieces incorrectly.

The ?-secretase complex – which cuts proteins at a specific place – plays a major role in the creation of these plaques.

However, this complex (group of proteins that work together) is also involved in the regulation of a series of other essential proteins such as Notch, which plays a crucial role in the development of an embryo.

This is why many of the medicines in development that act on the whole ?-secretase complex run up against toxic side effects.

Under the direction of Bart De Strooper, and in collaboration with researchers in other countries, Lutgarde Serneels, Jerome Van Biervliet and their colleagues have been studying the ?-secretase complex in a variety of tissues.

They have now been able to demonstrate that the complex assumes a different shape and function according to the tissue in which the secretase is active.

For their research on Alzheimer’s disease, the researchers used mouse models. They found that deactivating the variant, Aph1B ?-secretase, in Alzheimer mice leads to reduced formation of the plaques, without any harmful side effects.

With this discovery, the researchers are once again opening a way toward the development of medicines that deactivate ?-secretase.

By concentrating on a variant of the complex that cuts proteins specifically in the brain – the Aph1B ?-secretase complex – the formation of the plaques can be prevented, while the other functions of ?-secretase are not affected.

This raises hopes for a drug that, for the first time, will succeed in stopping Alzheimer’s disease.

The journal Science is publishing the results of this research. (ANI)

Just one ‘false’ amino acid can limit heart’s strength

Washington, March 6 (ANI): Scientists at the Heidelberg University Hospital in Germany have found that just one “false” amino acid can limit the strength of heart in zebrafish.

The researcher say that their finding attains significance as the fish have a genetic makeup similar to that of humans, and such defects could be critical for humans as well.

They point out that cardiac insufficiency is not just a disease that results from a heart attack or myocarditis, and that for young people, in particular, there is often an underlying genetic cause (cardiomyopathy).

The genetic variant that suffers from cardiomyopathy is called “Lazy Susan”, and got its nickname because of its slow blood flow.

When the researchers examined the muscle protein myosin light chain-1, which is involved in contraction of the heart muscle, they observed the crucial change in the amino acid Serine 195, which was lost through mutation.

The researchers say that this single change is sufficient to severely limit heart function.

Given that about 70 percent of the genes of zebrafish and humans are identical, the researchers say that these results are very important.

The Heidelberg cardiologists are currently planning to search for the same mutation in patients’ genes, hoping that their research may lead to new therapies for patients. (ANI)

Genetic variant linked to cocaine addiction identified

Washington, Mar 3 (ANI): In a novel study, an international team of researchers has identified a genetic variant linked to cocaine addiction and cocaine-induced paranoia.

They have discovered variant in gene called a-endomannosidase (MANEA) that contributes to cocaine dependence and related behaviours.

During the study, the researchers looked at 3,992 individuals from two family-based samples of European American and African American families, and were then genotyped for 11 markers spanning the MANEA gene.

The researchers found cocaine-induced paranoia was associated with six of the 11 markers in the European American family sample.

On the other hand, they found these six markers and three other markers were significant in the African American sample.

“Our findings suggest that cocaine dependence and associated behaviours may involve biological pathways not typically thought to be associated with brain metabolism and now opens a new pathway to understanding these highly prevalent disorders and their psychopathological manifestations,” said lead author Lindsay A. Farrer, PhD, chief of the Genetics Program and professor of medicine, neurology, genetics and genomics epidemiology and biostatistics at BUSM.

The team involved researchers from Boston University School of Medicine (BUSM) and Yale University School of Medicine and the University of Connecticut School of Medicine

The findings appear in the Archives of General Psychiatry. (ANI)

Gene variant associated with both autism and gastrointestinal dysfunction identified

Washington, March 3 (ANI): A specific gene variant that links increased genetic risk for autism with gastrointestinal (GI) conditions has been identified by scientists at the University of Southern California (USC) and Vanderbilt University.

Dr. Pat Levitt, director of the Zilkha Neurogenetic Institute at the Keck School of Medicine of USC and chair-designate of the Department of cell and neurobiology, says that the research team’s findings suggest that disrupted signalling of the MET gene may contribute to a syndrome that includes autism and co-occurring gastrointestinal dysfunction.

Autism is a developmental disorder characterized by deficits in communication abilities, social behaviour disruption and inflexible behaviour, according to background information in an article published in the journal Pediatrics.

Levitt and lead study author Dr. Daniel Campbell say that while gastrointestinal conditions are common among individuals with autism, researchers have long debated whether co-occurring GI dysfunction represents a unique autism subgroup.

“Gastrointestinal disorders don’t cause autism. Autism is a disorder of brain development. However, our study is the first to bring together genetic risk for autism and co-occurring GI disorders in a way that provides a biologically plausible explanation for why they are seen together so often,” Levitt says.

The researcher highlights the fact that the MET gene in the brain is expressed in developing circuits that are involved in social behaviour and communication, and that disturbances in its expression result in alterations in how these critical circuits develop and mature.

Levitt further says that research indicates that MET also plays an important role in development and repair of the GI system.

For their research, the team studied medical history records from 214 families in the Autism Genetic Resource Exchange (AGRE), and found that a variant in the MET gene was associated with autism specifically in those families where an individual had co-occurring autism and a GI condition.

According to Levitt, the study takes the research team a step further towards understanding the complex genetic risks for autism.

The researcher, however, concedes that further research is required, as different combinations of genes are likely to result in different types of autism features.

“We believe that there are other genes that will help identify different subgroups of individuals who have autism spectrum disorder.

We also believe that there needs to be research looking at whether the children with co-occurring GI dysfunction and autism have unique features that will help us predict what treatments will be best for them,” he says. (ANI)